Analyses of different ZYX expression groups (low/high level) in relation to survivals of patients demonstrated that overall survivals of NSCLC (in total), SCC, and AC patients were similar in each group (Figure 13A–D). Here, ZYX is linked to non-small cell lung carcinoma.